Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.3950 (3.46%) ($41.3950 - $41.4450) on Tue. Oct. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 41 | Latest Price | $41.3950(3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.4% a day on average for past five trading days. | Weekly Trend | HALO declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(41%) IFRA(34%) IWM(34%) IWO(34%) IWN(33%) | Factors Impacting HALO price | HALO will decline at least -1.195% in a week (0% probabilities). VIXM(-11%) VXX(-7%) TBT(-5%) UUP(-4%) USO(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | 2.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.14(3.13%) | 10 Day Moving Average | $39.55(4.66%) | 20 Day Moving Average | $40.3(2.72%) | To recent high | -20.1% | To recent low | 7.5% | Market Cap | $5.658b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |